Evidence map›Paper›PMID 31886168›Full record

ArticleBioMed research international2019

Trimethoxystilbene Reduces Nuclear Factor Kappa B, Interleukin-6, and Tumor Necrosis Factor-

Jie Shu, Wei Liu, Fei Han, Fanyan Luo

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. NF-κB and pulmonary hypertension: Advances in mechanistic research and therapeutic applications.American heart journal plus : cardiology research and practice · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jie ShuThe Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Wei LiuThe Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Fei HanThe Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Fanyan LuoThe Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.ORCID https://orcid.org/0000-0002-1195-4585
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary artery hypertension is a refractory disease that severely affects cardiopulmonary function, mainly resulting in irreversible pulmonary vascular remodeling. Current surgical treatment of this disease is not very effective and drug treatment is targeted at relieving symptoms, improving the quality of life of patients, and preventing disease progression. The purpose of this present study was to reveal the regulatory effects of trimethoxystilbene on the serum levels of nuclear factor kappa B, interleukin-6, and tumor necrosis factor-

Indexed as

AnimalsCytokinesDisease Models, AnimalFemaleImmunohistochemistryInterleukin-6LungMaleMonocrotalineNF-kappa BPregnancyPulmonary Arterial HypertensionPulmonary ArteryRatsRats, Sprague-DawleyTumor Necrosis Factor-alphaCytokinesInterleukin-6MonocrotalineNF-kappa BTumor Necrosis Factor-alpha

Identifiers

PMID31886168
PMCPMC6925919
OpenAlexW2989733824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.